 |
 |
 |
| |
ECLIPSE: A Pivotal Program Evaluating Once-Monthly Combination Therapy With Tobevibart and Elebsiran for Chronic HDV Infection - Rationale, Study Design, and Objectives
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Nancy Reau,1 Pietro Lampertico,2,3 Tarik Asselah,4 Michael A. Chattergoon,5 Tamara Palagashvili,5 Richie Phan,5 Cara Pilowa,5 Todd Correll5
1Division of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA; 2Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; 3CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; 4Université de Paris Cité, Hôpital Beaujon, AP-HP, INSERM UMR1149, Paris, France; 5Vir Biotechnology, Inc., San Francisco, CA, USA.




|
| |
|
 |
 |
|
|